StonvexLoading…
StonvexStonvexStonvexCore line items from HSDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $548.00K | $520.00K | $605.00K | $778.00K |
Operating Income | $-243.84M | $-13.90M | $-12.43M | $-15.52M |
Net Income | $-40.89M | $-11.74M | $-8.85M | $-14.07M |
EPS (Diluted) | $-1.85 | $-3282.26 | $-14.56 | $-52.13 |
Total Assets | $303.93M | $3.54M | $7.69M | $17.29M |
Total Liabilities | $3.02M | $2.48M | $5.34M | $9.14M |
Cash & Equivalents | $7.28M | $1.09M | $5.18M | $14.55M |
Free Cash Flow OCF − CapEx | Not available | $-11.05M | $-10.45M | $-14.33M |
Shares Outstanding | 43.74M | 4.94K | 714.59K | 564.09K |